BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’
| | |

BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’

On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…

The first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were licensed Both had independently developed plasma-based hepatitis B viral vaccines
| | |

The first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were licensed Both had independently developed plasma-based hepatitis B viral vaccines

In 1982, the first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were…